Yes I agree too. This is a really low valuation for this stock....

Yes I agree too. This is a really low valuation for this stock. I am disappointment in McColl and feel we have been shafted by management. The issue of shares to Lepu and their subsequent approval of the Merck deal makes me feel there are machinations that are not altogether fair. Bell Potter conservatively valued this share at $2.31. This share has been pushed down really hard and though some are happy, this deal is a farce! Hope we have a new bidder with a more respectable offer.